Roche Holding Ltd. (ROG) PT Set at CHF 258 by Deutsche Bank AG
Deutsche Bank AG set a CHF 258 target price on Roche Holding Ltd. (VTX:ROG) in a research note issued to investors on Wednesday morning. The brokerage currently has a neutral rating on the healthcare company’s stock.
A number of other equities analysts have also recently commented on ROG. J P Morgan Chase & Co reaffirmed a buy rating on shares of Roche Holding in a research note on Wednesday, June 7th. UBS AG set a CHF 260 price objective on Roche Holding and gave the stock a neutral rating in a research report on Thursday, July 6th. Goldman Sachs Group, Inc. (The) set a CHF 335 price objective on Roche Holding and gave the stock a buy rating in a research report on Thursday, July 20th. Societe Generale set a CHF 275 price objective on Roche Holding and gave the stock a neutral rating in a research report on Thursday, June 29th. Finally, Morgan Stanley set a CHF 260 price objective on Roche Holding and gave the stock a neutral rating in a research report on Wednesday, July 26th. Two research analysts have rated the stock with a sell rating, six have issued a hold rating and eight have issued a buy rating to the company. Roche Holding currently has a consensus rating of Hold and an average target price of CHF 267.73.
Roche Holding (VTX:ROG) opened at 247.90 on Wednesday. Roche Holding has a 52 week low of CHK 218.30 and a 52 week high of CHK 273.00. The firm has a market cap of CHK 211.52 billion and a P/E ratio of 22.01. The firm’s 50-day moving average price is CHK 244.39 and its 200 day moving average price is CHK 251.55.
COPYRIGHT VIOLATION WARNING: This piece was published by Watch List News and is owned by of Watch List News. If you are viewing this piece on another website, it was illegally copied and reposted in violation of United States and international copyright & trademark laws. The original version of this piece can be accessed at https://www.watchlistnews.com/roche-holding-ltd-rog-pt-set-at-chf-258-by-deutsche-bank-ag/1616366.html.
Roche Holding Company Profile
Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.
Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with Analyst Ratings Network's FREE daily email newsletter.